WELLINGTON MANAGEMENT GROUP LLP – Alnylam Pharmaceuticals, Inc. Transaction History
WELLINGTON MANAGEMENT GROUP LLP portfolio value:
$1.19B
portfolio value
WELLINGTON MANAGEMENT GROUP LLP quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2.43% | 141.42K shares | 344.00M | $200.16 | 5.95M |
| Q2 2022 | share | Decrease | -17.37% | -1.22M shares | -300.85M | $145.85 | 5.81M |
| Q1 2022 | share | Increase | +2.78% | 190.05K shares | -12.01M | $163.29 | 7.03M |
| Q4 2021 | share | Decrease | -7.14% | -526.64K shares | -231.05M | $171.03 | 6.84M |
| Q3 2021 | share | Decrease | -19.69% | -1.80M shares | -164.20M | $188.81 | 7.37M |
| Q2 2021 | share | Increase | +0.33% | 30.53K shares | 264.33M | $169.52 | 9.17M |
| Q1 2021 | share | Decrease | -9.04% | -908.99K shares | -15.50M | $141.19 | 9.14M |
| Q4 2020 | share | Decrease | -0.79% | -80.58K shares | -168.92M | $129.97 | 10.05M |
| Q3 2020 | share | Decrease | -3.19% | -334.20K shares | -74.94M | $145.6 | 10.13M |
| Q2 2020 | share | Decrease | -14.77% | -1.81M shares | 213.55M | $148.11 | 10.47M |
| Q1 2020 | share | Decrease | -14.00% | -1.99M shares | -307.95M | $108.85 | 12.28M |
| Q4 2019 | share | Decrease | -3.68% | -546.43K shares | 452.51M | $115.17 | 14.28M |
| Q3 2019 | share | Decrease | -0.21% | -31.06K shares | 114.33M | $80.42 | 14.83M |
| Q2 2019 | share | Increase | +0.21% | 31.37K shares | -307.57M | $72.56 | 14.86M |
| Q1 2019 | share | Increase | +5.45% | 766.37K shares | 360.53M | $93.45 | 14.83M |
| Q4 2018 | share | Increase | +7.94% | 1.03M shares | -114.93M | $72.91 | 14.06M |
| Q3 2018 | share | Increase | +10.58% | 1.24M shares | -20.13M | $87.52 | 13.03M |
| Q2 2018 | share | Increase | +22.71% | 2.18M shares | 16.90M | $98.49 | 11.78M |
| Q1 2018 | share | Increase | +4.58% | 420.63K shares | -22.90M | $119.1 | 9.60M |
| Q4 2017 | share | Decrease | -18.75% | -2.11M shares | -161.15M | $127.05 | 9.18M |
| Q3 2017 | share | Decrease | -4.78% | -567.73K shares | 381.11M | $117.49 | 11.30M |
| Q2 2017 | share | Decrease | -1.43% | -172.13K shares | 329.56M | $79.76 | 11.86M |
| Q1 2017 | share | Increase | +0.26% | 31.20K shares | 167.45M | $51.25 | 12.04M |
| Q4 2016 | share | Increase | +0.10% | 12.49K shares | -363.53M | $37.44 | 12.00M |
| Q3 2016 | share | Increase | +0.21% | 25.69K shares | 148.87M | $67.78 | 11.99M |
| Q2 2016 | share | Increase | +0.22% | 26.17K shares | -85.51M | $55.49 | 11.97M |
| Q1 2016 | share | Increase | +12.09% | 1.28M shares | -253.46M | $62.77 | 11.94M |